Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer

NCT07116213 is registered in ClinicalTrials.gov with Xiaorong Hou as lead sponsor.

NCT NCT07116213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07116213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer
Lead sponsor
Xiaorong Hou
Phase
Not applicable
Overall status
Recruiting
Start date
June 30, 2025
Completion date
December 30, 2030
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, hypofractionated dose, radiotherapy, adjuvant, side effects, survival , tumor